Osama I Alwassil (Osama L Alwassil)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

Antibiotics (Basel, Switzerland)

Molecules (Basel, Switzerland)

Drug design, development and therapy

PloS one

King Saud bin Abdulaziz University for Health Sciences

VCU MCV (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King Saud bin Abdulaziz University for Health Sciences Sep 11 2017

Saudi Arabia

Assistant Professor of Medicinal Chemistry :: COP, Pharmaceutical Sciences

King Faisal University Aug 18 2015 - Jun 21 2017

Saudi Arabia

Assistant Professor of Medicinal Chemistry :: Pharmaceutical Sciences

Education History

VCU MCV Aug 18 2012 - Aug 18 2015

United States

PHD :: Medicinal Chemistry, School of Pharmacy

Publications

Saima Gulshan, Shahid Shah, Pervaiz Akhtar Shah, Muhammad Irfan, Malik Saadullah, Ghulam Abbas, Muhammad Hanif, Akhtar Rasul, Nabeel Ahmad, Abid Mahmood, Ejaz Basheer, Mohammad Omer Habib, Hadil Faris Alotaibi, Ahmad J Obaidullah, Jawza F Alsabhan, Osama I Alwassil
Development and Pharmacokinetic Evaluation of Novasomes for the Trans-nasal Delivery of Fluvoxamine Using Arachidonic Acid-Carboxymethyl Chitosan Conjugate. Pharmaceutics 15 (9) (2023)
Ahmad J Obaidullah, A F M Motiur Rahman, Nawaf A Alsaif, Ashwag S Alanazi, Hussam Albassam, Ahmed Z Alanazi, Osama I Alwassil, Ali Musfer Alqahtani, Abu Montakim Tareq
Network Pharmacology- and Molecular Docking-Based Identification of Potential Phytocompounds from Argyreia capitiformis in the Treatment of Inflammation. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Katharigatta Narayanaswamy Venugopala, Sandeep Chandrashekharappa, Christophe Tratrat, Pran Kishore Deb, Rahul D Nagdeve, Susanta K Nayak, Mohamed A Morsy, Pobitra Borah, Mohamad Fawzi Mahomodally, Raghu Prasad Mailavaram, Mahesh V Attimarad, Bandar E Al-Dhubiab, Sreeharsha Nagaraja, Anroop Balachandran Nair, Osama I Alwassil, Michelyne Haroun, Viresh Mohanlall, Pottathil Shinu, Rashmi Venugopala, Mahmoud Kandeel, Belakatte P Nandeshwarappa, Yasmine F Ibrahim
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives. Molecules (Basel, Switzerland) 26 (12) (2021)
Katharigatta Narayanaswamy Venugopala, Mohammed A Khedr, Yarabahally R Girish, Subhrajyoti Bhandary, Deepak Chopra, Mohamed A Morsy, Bandar E Al-Dhubiab, Pran Kishore Deb, Mahesh V Attimarad, Anroop Balachandran Nair, Nagaraja Sreeharsha, Rashmi Venugopala, Mahmoud Kandeel, Sabah H Akrawi, Madhusudana Reddy M B, Sheena Shashikanth, Osama I Alwassil, Viresh Mohanlall
Crystallography, in Silico Studies, and In Vitro Antifungal Studies of 2,4,5 Trisubstituted 1,2,3-Triazole Analogues. Antibiotics (Basel, Switzerland) 9 (6) (2020)
Katharigatta Narayanaswamy Venugopala, Christophe Tratrat, Melendhran Pillay, Sandeep Chandrashekharappa, Omar Husham Ahmed Al-Attraqchi, Bandar E Al-Dhubiab, Mahesh V Attimarad, Osama I Alwassil, Anroop Balachandran Nair, Sreeharsha Nagaraja, Rashmi Venugopala, Mohamed A Morsy, Micheline Haroun, Hezekiel M Kumalo, Bharti Odhav, Koleka P Mlisana
In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against Mycobacterium tuberculosis. Drug design, development and therapy 14 (2020)
Katharigatta Narayanaswamy Venugopala, Pushpalatha Ramachandra, Christophe Tratrat, Gleiser Raquel Miranda, Subhrajyoti Bhandary, Deepak Chopra, Mohamed A Morsy, Bandar E Al-Dhubiab, Mahesh V Attimarad, Anroop Balachandran Nair, Sreeharsha Nagaraja, Rashmi Venugopala, Pran Kishore Deb, Sandeep Chandrashekharappa, Hany Ezzat Khalil, Osama I Alwassil, Sara Nidal Abed, Yazan A Bataineh, Ramachandra Palenge, Michelyne Haroun, Shinu Pottathil, Girish Meravanige Basavarajappa, Sabah H Akrawi, Viresh Mohanlall
Larvicidal Activities of 2-Aryl-2,3-Dihydroquinazolin -4-ones against Malaria Vector Anopheles arabiensis, In Silico ADMET Prediction and Molecular Target Investigation. Molecules (Basel, Switzerland) 25 (6) (2020)
Osama I Alwassil, Sandeep Chandrashekharappa, Susanta K Nayak, Katharigatta Narayanaswamy Venugopala
Design, synthesis, and structural elucidation of novel NmeNANAS inhibitors for the treatment of meningococcal infection. PloS one 14 (10) (2019)
Katharigatta Narayanaswamy Venugopala, Christophe Tratrat, Melendhran Pillay, Mohamad Fawzi Mahomodally, Subhrajyoti Bhandary, Deepak Chopra, Mohamed A Morsy, Michelyne Haroun, Bandar E Al-Dhubiab, Mahesh V Attimarad, Anroop Balachandran Nair, Sreeharsha Nagaraja, Rashmi Venugopala, Sandeep Chandrashekharappa, Osama I Alwassil, Bharti Odhav
Anti-Tubercular Activity of Substituted 7-Methyl and 7-Formylindolizines and In Silico Study for Prospective Molecular Target Identification. Antibiotics (Basel, Switzerland) 8 (4) (2019)

Osama I Alwassil.css-eqlu8i{font-size:small;padding-left:4px;} (Osama L Alwassil)

Publication Activity (10 Years)

Top Topics

Top Venues

Osama I Alwassil (Osama L Alwassil)